Vivos Inc (RDGL)

[Drugdoctor]

I'm sorry but that is one TERRIBLE 10Q...

Now this wasn't so bad and was expected...

NOTE 8: STOCKHOLDERS’ EQUITY



Common Stock



During the six months ending June 30, 2018 the Company issued 41,146,060 shares of its common stock valued at $376,181 for conversion of convertible debt, 10,000 shares of its common stock valued at $449 for services, 9,666,670 shares of its common stock valued at $3,972,942 for conversions of 966,667 shares of Series A Preferred, and 1,240,000 shares of its common stock valued at $1,240 in the form of Restricted Stock Units.

That is conversion of common shares 41.1 million x .0091 = $376,181

But this is TERRIBLE...


May 2017 $2,332,305 Notes convertible into common stock after April 15, 2018 at a 45% discount to lowest trade price for previous 30 days ($0.0017 at June 30, 2018), 7.5% interest, due May 2018 therefore in default as of June 30, 2018, net of debt discounts of $0 and $544,845, respectively

Yep, if this note is converted at the above price... 1371944117 shares of stock will have to be issued... And that's not all the notes due... Authorized shares will have to be raised and/or a REVERSE SPIT done to continue in business, unless some financial miracle is found...

GLTA